new retatrutide Buy Peptide Sciences 20mg / $172 only A New Obesity Drug Delivered

Disclaimer: This article is educational and is not medical advice

Published clinical trial data generally shows higher average weight loss with brand-name tirzepatide than with brand-name semaglutide in controlled conditions - approximately 20.9% body weight reduction with tirzepatide in the SURMOUNT-1 trial versus approximately 14.9% with semaglutide in the STEP-1 trial

While its still new, scientists are excited about its potential, as it has shown significant results in treating obesity

Currently licensed standard-dose diabetes tablets in the UK generally yield lower average weight loss results than dedicated weight loss injections